On July 12, 2013, SUGARMAN principal, Marianne LeBlanc was quoted in Boston Business Journal’s article Boston Scientific sees flood of suits over surgical mesh. Here’s an excerpt:
Boston Scientific sees flood of suits over surgical mesh
Boston Scientific Corp. (NYSE: BSX) and five other medical device companies are facing a flurry of new lawsuits over a product to treat pelvic organ prolapse in women, as a two-year statute of limitations in many states approaches. […]
“You can boil it down to, the manufacturers knew, or should have known, that there were problems with the product,” said Marianne LeBlanc, a principal at SUGARMAN & SUGARMAN, a Boston law firm that represents a number of plaintiffs in suits against Boston Scientific.
LeBlanc said tl1at Massachusetts’ statute of limitations in such cases is three years. But many patients are filing lawsuits now ahead of a bellwether case – one chosen by the court as representative of several other cases tiled on the same issue – scheduled to go to trial in January 2014 in Middlesex Superior Court. LeBlanc said that the damages that are being sought vary widely – ranging from the cost of medical care, to lost income, to spouses of patients who claim they’re no longer able to have sex with their partners.
“There are cases where women have died,” she said.
For the full article, visit Boston Scientific sees flood of suits over surgical mesh